Oncology Working Group
PharmaWrite's Oncology Working Group (OWG) is an innovative partnership that teams PharmaWrite's oncology franchise writers and managers with four experienced oncology professionals, including an oncology regulatory expert and three veteran oncology pharmacy clinicians who are involved in the oncology clinical setting daily—treating patients, monitoring adverse events, working with new products in oncology. PharmaWrite's scientific staff not only consults with the OWG members regularly, but works closely with them to incorporate their clinical and scientific knowledge into PharmaWrite's medical communications work, including abstracts, posters, manuscripts, gap analyses, therapeutic area surveillance, needs assessments, thought leader engagement, advisory board content, and business development.
OWG members are involved at all levels of PharmaWrite's medical communications activities, including medical writing, content review, strategy development, and regulatory consulting. Members also attend conferences on PharmaWrite's behalf in order to monitor competitive data and new clinical advances in oncology. Finally, OWG members also provide scientific and strategic input to, and present at, PharmaWrite's business development presentations in oncology. The PharmaWrite OWG members are:
Dr. Pereiras's areas of expertise include hematology/liquid tumors, hematopoietic stem cell transplant, and palliative care. She has considerable experience in advising P&T committees on therapeutic options in oncology. Dr. Pereiras does clinical rounds in stem cell transplant, pain/palliative care, and drug information at Hackensack University Medical Center in New Jersey. She has also been investigator or subinvestigator for several hospital-based treatment initiatives at Hackensack Meridian Health Dr. Pereiras teaches at the Ernest Mario School of Pharmacy, Rutgers University, on topics including oncology therapeutics, gerontology, pain management, palliative care, infectious diseases in oncology, and advanced pharmacotherapy applications.
Dr. Nightingale's key areas oncology expertise include solid tumors (sarcomas, carcinomas) and medication-related issues such as polypharmacy, inappropriate medication use, and adverse drug events, particularly in senor adults living with cancer. She is Advanced Practice Pharmacist in Medical Oncology at Thomas Jefferson University Hospital in Philadelphia, where her clinical duties include providing medication therapy management services, medication adherence counseling, and medication education. She also teaches on medication safety, clinical diagnosis/ pharmacotherapy, pharmacology, inpatient care, anemia, and biostatistics in the Department of Pharmacy Practice at Jefferson College of Pharmacy, Thomas Jefferson University.
Dr. Lopez is a New York-based hematologist/oncologist who specializes in pediatrics, including pediatric oncology and rare diseases in children. She is Clinical Pharmacy Manager in Pediatric BMT/Oncology, NewYork-Presbyterian/Morgan Stanley Children's Hospital at Columbia University Medical Center, where she provides, in collaboration with healthcare providers, comprehensive pharmaceutical care and disease management in patient care rounds, quality improvement projects such as development/maintenance of guidelines/pathways/order sets, and active committee participation.
Dr. Allard is a 30-year veteran of the pharmaceutical, biopharmaceutical, and medical device industries. His areas of expertise include regulatory approval pathways (US and EU), oncology therapeutics (solid and liquid tumors), and treatments for chemotherapy-induced neuropathies/neuropathic pain. Dr. Allard has held executive-level positions at several US and European pharmaceutical and device firms, has overseen phase 1-3 clinical activities across multiple therapeutic areas, and has been instrumental in bringing several important products to market in both the US and EU.
